Abstract
Patients presenting with neurological deficits and/or pain due to spinal metastasis usually require immediate or subacute surgical treatment. Nevertheless, it is unclear whether or not side effects of primary cancer location might influence postoperative complication rate. We therefore analyzed our spinal database to identify factors influencing early postoperative complications after surgery for symptomatic spinal metastases. From 2013 to 2017, 163 consecutive patients suffering from symptomatic spinal metastases were treated at our department. Early postoperative complications were defined as any postoperative event requiring additional medical or surgical treatment within 30 days of spinal surgery. A multivariate regression analysis was performed to identify independent predictors for postoperative complications after surgery for spinal metastasis. Overall, 39 of 163 patients who underwent spinal surgery for spinal metastasis developed early postoperative complications throughout the treatment course (24%). Preoperative ASA score ≥ 3 (p = 0.003), preoperative C-reactive protein level > 10 mg/l (p = 0.008), preoperative Karnofsky Performance Score < 60% (p = 0.03), radiation treatment within 2 months of surgery (p = 0.01), presence of diabetes mellitus (p = 0.008), and preoperative complete neurological impairment (p = 0.04) were significant and independent predictors for early postoperative complications in patients with surgery for spinal metastasis. The ability to preoperatively predict postoperative complication risk is valuable to select critically ill patients at higher risk requiring special attention. Therefore, the present study identified several significant and independent risk factors for the development of early postoperative complication in patients who underwent surgery for spinal metastasis.
Similar content being viewed by others
References
Yoshihara H, Yoneoka D (2014) Trends in the surgical treatment for spinal metastasis and the in-hospital patient outcomes in the United States from 2000 to 2009. Spine J 14(9):1844–1849
Kelly ML, Kshettry VR, Rosenbaum BP, Seicean A, Weil RJ (2014) Effect of a randomized controlled trial on the surgical treatment of spinal metastasis, 2000 through 2010: a population-based cohort study. Cancer 120(6):901–908
Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648
Carl HM, Ahmed AK, Abu-Bonsrah N, De la Garza Ramos R, Sankey EW, Pennington Z, Bydon A, Witham TF, Wolinsky JP, Gokaslan ZL, Sacks JM, Goodwin CR, Sciubba DM (2018) Risk factors for wound-related reoperations in patients with metastatic spine tumor. J Neurosurgery Spine 28(6):663–668
Lau D, Leach MR, Than KD, Ziewacz J, La Marca F, Park P (2013) Independent predictors of complication following surgery for spinal metastasis. European Spine J : Official Publication European Spine Soc, European Spinal Deformity Soc, European Section Cervical Spine Res Soc 22(6):1402–1407
Pereira NRP, Ogink PT, Groot OQ, Ferrone ML, Hornicek FJ, van Dijk CN, Bramer JAM, Schwab JH (2018) Complications and reoperations after surgery for 647 patients with spine metastatic disease. Spine J
Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz LT (1999) Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine 24(18):1943–1951
Sailhan F, Prost S, Zairi F, Gille O, Pascal-Mousselard H, Bennis S, Charles YP, Blondel B, Fuentes S, French Spine S (2018) Retrospective multicenter study by the French Spine Society of surgical treatment for spinal metastasis in France. Orthop Traumatol Surg Res
Lau D, Leach MR, La Marca F, Park P (2012) Independent predictors of survival and the impact of repeat surgery in patients undergoing surgical treatment of spinal metastasis. J Neurosurgery Spine 17(6):565–576
Missenard G, Lapresle P, Cote D (1996) Local control after surgical treatment of spinal metastatic disease. European Spine J : Official Publication European Spine Soc, European Spinal Deformity Soc, European Section Cervical Spine Res Soc 5(1):45–50
Sebaaly A, Shedid D, Boubez G, Zairi F, Kanhonou M, Yuh SJ, Wang Z (2018) Surgical site infection in spinal metastasis: incidence and risk factors. Spine J
Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487–48490
Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61(9):824–833
Mok JM, Pekmezci M, Piper SL, Boyd E, Berven SH, Burch S, Deviren V, Tay B, Hu SS (2008) Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications. Spine 33(4):415–421
Santonocito C, De Loecker I, Donadello K, Moussa MD, Markowicz S, Gullo A, Vincent JL (2014) C-reactive protein kinetics after major surgery. Anesth Analg 119(3):624–629
Shiozaki A, Fujiwara H, Okamura H, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Otsuji E (2012) Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett 3(4):907–912
Fujiwara H, Suchi K, Okamura S, Okamura H, Umehara S, Todo M, Shiozaki A, Kubota T, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E (2011) Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. J Surg Oncol 103(1):62–68
Fu KM, Smith JS, Polly DW, Jr., Ames CP, Berven SH, Perra JH, McCarthy RE, Knapp DR, Jr., Shaffrey CI, Scoliosis Research Society M, Mortality C (2011) Correlation of higher preoperative American Society of Anesthesiology grade and increased morbidity and mortality rates in patients undergoing spine surgery. J Neurosurgery Spine 14 (4):470–474
Whitmore RG, Stephen JH, Vernick C, Campbell PG, Yadla S, Ghobrial GM, Maltenfort MG, Ratliff JK (2014) ASA grade and Charlson Comorbidity Index of spinal surgery patients: correlation with complications and societal costs. Spine J 14(1):31–38
Choi D, Fox Z, Albert T, Arts M, Balabaud L, Bunger C, Buchowski JM, Coppes MH, Depreitere B, Fehlings MG, Harrop J, Kawahara N, Martin-Benlloch JA, Massicotte EM, Mazel C, Oner FC, Peul W, Quraishi N, Tokuhashi Y, Tomita K, Verlaan JJ, Wang M, Crockard HA (2015) Prediction of quality of life and survival after surgery for symptomatic spinal metastases: a multicenter cohort study to determine suitability for surgical treatment. Neurosurgery 77(5):698–708 discussion 708
Freedman MK, Hilibrand AS, Blood EA, Zhao W, Albert TJ, Vaccaro AR, Oleson CV, Morgan TS, Weinstein JN (2011) The impact of diabetes on the outcomes of surgical and nonsurgical treatment of patients in the spine patient outcomes research trial. Spine 36(4):290–307
Guzman JZ, Iatridis JC, Skovrlj B, Cutler HS, Hecht AC, Qureshi SA, Cho SK (2014) Outcomes and complications of diabetes mellitus on patients undergoing degenerative lumbar spine surgery. Spine 39(19):1596–1604
Demura S, Kawahara N, Murakami H, Nambu K, Kato S, Yoshioka K, Okayama T, Tomita K (2009) Surgical site infection in spinal metastasis: risk factors and countermeasures. Spine 34(6):635–639
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30(19):2186–2191
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
The present study was approved by the local ethics committee of the University of Bonn (092/18).
Informed consent
Informed consent was not sought as a retrospective study design was used.
Rights and permissions
About this article
Cite this article
Schuss, P., Güresir, Á., Schneider, M. et al. Factors influencing early postoperative complications following surgery for symptomatic spinal metastasis: a single-center series and multivariate analysis. Neurosurg Rev 43, 211–216 (2020). https://doi.org/10.1007/s10143-018-1032-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-018-1032-3